Medicine and Dentistry
Patient
100%
Infective Endocarditis
85%
Blood Culture
46%
Hemolytic
44%
Bloodstream Infection
36%
Retrospective Cohort Study
27%
Heart Valve Prosthesis
23%
Cohort Analysis
21%
Aerococcus
21%
Culture
15%
Odds Ratio
13%
Medical Record
11%
Person
11%
Echocardiography
11%
Antimicrobial Therapy
10%
Prognostic Factor
9%
Antibody Response
9%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Immunoglobulin M
9%
Heart Surgery
9%
Campylobacter
9%
Infectious Complication
9%
Encephalitis
9%
Observational Study
9%
Immunoassay
9%
Aortitis
9%
COVID-19
9%
Morganella morganii
9%
Antimicrobial Agent
9%
Extended Spectrum Beta Lactamase
9%
Carbapenem Derivative
9%
Therapeutic Procedure
8%
Age
6%
All Cause Mortality
5%
Surgery
5%
Mortality
5%
Blood
5%
Man
5%
Pharmacology, Toxicology and Pharmaceutical Science
Bacterial Endocarditis
79%
Cohort Study
31%
Bacteremia
27%
Observational Study
22%
Antibodies
18%
SARS Coronavirus
15%
Infection
14%
Antibiotics
10%
Disease Course
10%
Retrospective Study
9%
DNA 16S
9%
Endocarditis
9%
Bloodstream Infection
9%
Procoagulant
6%
Immunology and Microbiology
Biofilm
26%
Staphylococcus Aureus
14%
Microbiology
13%
Monocyte
9%
Micrococcus
9%
Campylobacter
9%
COVID-19
9%
Abiotrophia defectiva
9%
Antimicrobial Resistance
9%
Antimicrobial Agent
9%
Aortic Valve
9%
Enterobacterales
9%
Bacterium
8%
Matrix-Assisted Laser Desorption-Ionization
5%
Thrombin
5%
Platelet
5%
Heart Valve
5%
Genus
5%
Clinical Microbiology
5%
